Dual Time Point PET Imaging in Lymphoma
NCT00297557 · Status: UNKNOWN · Type: OBSERVATIONAL
Last updated 2006-10-11
Summary
Comparison of single time point with dual time point PET imaging in the accuracy of diagnosing active lymphoma. Biopsy results or clinical/radiological progression will be used in conjunction with the PET data.
Conditions
- Hodgkin's or Non-Hodgkin's Lymphoma
Sponsors & Collaborators
-
Royal Marsden NHS Foundation Trust
lead OTHER
Principal Investigators
-
Dr Gary Cook · Royal Marsden NHS Foundation Trust
Eligibility
- Min Age
- 16 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
More Related Trials
-
Detection and Characterization of Residual Masses in Lymphomas
NCT02300402 ·Status: COMPLETED
-
PET-CT in Lymphoma Among the Eldery
NCT07259941 ·Status: NOT_YET_RECRUITING
-
Assessment of Hematopoietic Recovery Following Chemotherapy for Non-Hodgkin's Lymphoma
NCT00775957 ·Status: TERMINATED
-
Optimization of 18F-FDG PET/CT Response Assessment and Prognostic Evaluation Strategies for High-Metabolism Lymphoma
NCT06795113 ·Status: RECRUITING
-
PET Imaging Targeting Granzyme B Predicts Immunotherapy Efficacy in Diffuse Large B-cell Lymphoma
NCT06755775 ·Status: RECRUITING
-
Early Evaluation of the Response of Large B Cell Non Hodgkin's Lymphoma to Chemotherapy by PET/CT
NCT00256490 ·Status: COMPLETED ·Phase: NA
-
The Performance of Multi-tracer Multimodality PET in Lymphoma
NCT05004961 ·Status: UNKNOWN
-
PET Scan in Planning Treatment in Patients Undergoing Combination Chemotherapy For Stage IA or Stage IIA Hodgkin Lymphoma
NCT00943423 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
18F-FDG PET/CT-based Prognostic Model for Predicting Outcome in Patients With Diffuse Large B-cell Lymphoma
NCT02928861 ·Status: UNKNOWN ·Phase: NA
-
Prospective Comparison Between FDG-PET/MR and FDG-PET/CT in Classical Hodgkin Lymphoma and DLBC Non-Hodgkin Lymphoma
NCT03042247 ·Status: UNKNOWN
-
Lymph Node Assessment Using Simultaneous 18F-FDG-PET and MRI
NCT02180308 ·Status: COMPLETED
-
Interest of a Systematic One-year Monitoring by 18F-FDG PET-CT
NCT04464590 ·Status: COMPLETED
-
Dual Point PET Scan in Early Stage Hodgkin Lymphoma Patients With Bulky Lesions
NCT01399931 ·Status: UNKNOWN
-
Diagnostic Qualities of the Positron Emission Tomography Coupled to the Scanner (PET / CT) in the Assessment of Response to Non-Hodgkin's Lymphoma Therapy in Children and Adolescents
NCT02488369 ·Status: COMPLETED ·Phase: NA
-
Study of the Angiogenesis by PET/CT in Patients With Lymphoma
NCT02490891 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluating 18F-FDG PET/CT With Liver SUVmax-based Criteria for Prognosis of Patients With Diffuse Large B-cell Lymphoma
NCT02931201 ·Status: UNKNOWN ·Phase: NA
-
Comparison of Whole-body MRI, Circulating DNA and PET-CT in Staging, Prognosis, and Treatment Response in Patients with Diffuse Large Cell B Lymphoma
NCT06777290 ·Status: COMPLETED
-
Early On-therapy PET at First-line Treatment in Diffuse Large B-cell Lymphoma Stage IIB-IV
NCT00286832 ·Status: COMPLETED
-
18F-FDG PET Radiomics of Diffuse Large B-cell Lymphoma
NCT04317313 ·Status: COMPLETED
-
PET/CT Vs Bone Marrow Biopsy in Exclusion of Bone Marrow Infiltration for Initial Staging of Lymphoma
NCT05565898 ·Status: NOT_YET_RECRUITING
-
The Value of Artificial Intelligence-based 18F-FDG PET/CT in Diferential Diagnosis, Efficacy Prediction and Prognosis Prediction of T-NK Cell Lymphoma: a Clinical Study
NCT06747299 ·Status: NOT_YET_RECRUITING
-
MRI Compared to PET/CT for Staging and Treatment Response in Lymphoma
NCT02733887 ·Status: UNKNOWN ·Phase: NA
-
Whole-Body MRI and Conventional Imaging in Detecting Distant Metastases in Young Patients With Solid Tumors or Lymphoma
NCT00072488 ·Status: UNKNOWN ·Phase: NA
-
Use of FDG PET as Predictor of Residual Disease and Subsequent Relapse in Patients With NHL and HD Undergoing HDC and ASCT
NCT00534989 ·Status: COMPLETED ·Phase: NA
-
Mammography SPECT With Rotating Slant Hole Collimator
NCT00328354 ·Status: WITHDRAWN